Enhanced Vasoconstriction in Sickle Cell Disease is Dependent on ETA Receptor Activation

John Miller Allan,Brandon M Fox,Malgorzata Kasztan,Gillian C Kelly,Patrick A Molina,McKenzi A King,Jackson Colson,Leigh Wells,Latanya Bowman,Marsha Blackburn,Abdullah Kutlar,Ryan A Harris,David M Pollock,Jennifer Pollock
DOI: https://doi.org/10.1042/cs20240625
2024-11-16
Clinical Science
Abstract:Sickle Cell Disease (SCD) carries a significant risk for poor vascular health and vascular dysfunction. High levels of vascular reactive oxygen species (ROS) as well as elevated plasma endothelin-1 (ET-1), a potent vasoconstrictor with actions via the ETA receptor, are both common phenotypes in SCD. Alpha-1 adrenergic receptor activation is a major mediator of stress-induced vasoconstriction. However, the mechanism of the SCD enhanced vasoconstrictive response is unknown. We hypothesized that...
medicine, research & experimental
What problem does this paper attempt to address?